divided 150 postmenopausal Chinese women into osteoporosis group, osteopenia group, and healthy control group based on their BMD, and assessed serum bile acid, FGF19, and bone turnover biomarker levels (20). The gene discussed is FGF19; the disease is osteoporosis.